Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Alagna

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Intensive Care Medicine|May 26, 2019
Fecal microbiota transplantation in the ICU: perspectives on future implementationsLaura Alagna, Bastiaan W Haak, Andrea Gori
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2020
Fecal Microbiota Transplant: Keep Calm and Carry On, Learning From ExperienceDavide Mangioni, Laura Alagna, Andrea Gori, et al.
Critical Care Medicine|January 17, 2018
The authors replyGiacomo Grasselli, Vittorio Scaravilli, Laura Alagna, et al.
Journal of Chemotherapy (Florence, Italy)|August 19, 2021
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samplesSara Baldelli, Matteo Cerea, Davide Mangioni, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 27, 2026
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Lung Transplantation: Clinical Evidence, Safety, and PK/PD PropertiesAndrea Lombardi, Davide Mangioni, Giulia Viero, et al.
Chest|September 7, 2021
ResponseGiacomo Grasselli, Vittorio Scaravilli, Davide Mangioni, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2024
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD PropertiesAndrea Lombardi, Laura Alagna, Emanuele Palomba, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 18, 2020
Coronavirus disease 2019 and transplantation: A view from the insideAndrea Gori, Daniele Dondossola, Barbara Antonelli, et al.
The New Microbiologica|September 7, 2007
Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapyAnna De Bona, Laura Galli, Giulia Gallotta, et al.
Frontiers in Immunology|March 27, 2023
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVIDGiuseppe Ancona, Laura Alagna, Claudia Alteri, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Intensive Care Medicine|May 26, 2019
Fecal microbiota transplantation in the ICU: perspectives on future implementationsLaura Alagna, Bastiaan W Haak, Andrea Gori
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2020
Fecal Microbiota Transplant: Keep Calm and Carry On, Learning From ExperienceDavide Mangioni, Laura Alagna, Andrea Gori, et al.
Critical Care Medicine|January 17, 2018
The authors replyGiacomo Grasselli, Vittorio Scaravilli, Laura Alagna, et al.
Journal of Chemotherapy (Florence, Italy)|August 19, 2021
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samplesSara Baldelli, Matteo Cerea, Davide Mangioni, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 27, 2026
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Lung Transplantation: Clinical Evidence, Safety, and PK/PD PropertiesAndrea Lombardi, Davide Mangioni, Giulia Viero, et al.
Chest|September 7, 2021
ResponseGiacomo Grasselli, Vittorio Scaravilli, Davide Mangioni, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2024
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD PropertiesAndrea Lombardi, Laura Alagna, Emanuele Palomba, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 18, 2020
Coronavirus disease 2019 and transplantation: A view from the insideAndrea Gori, Daniele Dondossola, Barbara Antonelli, et al.
The New Microbiologica|September 7, 2007
Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapyAnna De Bona, Laura Galli, Giulia Gallotta, et al.
Frontiers in Immunology|March 27, 2023
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVIDGiuseppe Ancona, Laura Alagna, Claudia Alteri, et al.
Pageof 5